Windows into estradiol effects in Alzheimer's disease therapy

European Review for Medical and Pharmacological Sciences

Volumn 15, Issue 10, 2011, Pages 1131-1140

  Mohamd, E M ^a   Ahmed, Hanaa H ^b   Estefan, S F ^b   Farrag, A E R H ^b   Salah, R S ^b  

^a Tanta University   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Aluminum; Alzheimer's disease; Estradiol; Ovariectomy; Plaques

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ALUMINUM CHLORIDE; BRAIN DERIVED NEUROTROPHIC FACTOR; CATALASE; ESTRADIOL; HYDROGEN PEROXIDE; MALONALDEHYDE; PROTEIN BCL 2; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; NERVE CELL; NONHUMAN; OVARIECTOMY; RAT;

ALUMINUM COMPOUNDS; ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHLORIDES; ESTRADIOL; FEMALE; MALONDIALDEHYDE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY;

EID: 82455167081     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. CANDORE G, BULATI M, CARUSO C, CASTIGLIA L, COLONNA-ROMANO G, DI-BONA D, DURO G, LIO D, MATRANGA D, PELLICANO M, RIZZO C, SCAPAGNINI G, VASTO S. Inflammation, cytokines, immune response, apolipoprotein E, cholesterol and oxidative stress in Alzheimer's disease: therapeutic implications. Rejuvenation Res 2010; 13: 301-313.
2. ALUISE CD, ROBINSON RA, BECKETT TL, MURPHY MP, CAI J, PIERCE WM, MARKESBERY WR, BUTTERFIELD DA. Pre-clinical Alzheimer's disease: brain oxidative stress, amyloid- beta peptide and proteomics. Neurobiol Dis 2010; 39: 221-228.
3. RANDALL AD, WITTON J, BOOTH C, HYNES-ALLEN A, BROWN JT. The functional neurophysiology of the amyloid precursor protein (APP) processing pathway. Neuropharmacology 2010; 59: 243-267.
4. GROSGEN S, GRIMM MO, FRIEB P, HARTMANN T. Role of amyloid-beta in lipid homeostasis. Biochim Biophys Acta 2010; 1801: 966-974.
5. GOMEZ M, ESPARZA JL, CABRE M, GARCIA T, DOMINGO JL. Aluminum exposure through the diet: metal levels in APP-β transgenic mice a model for Alzheimer's disease. Toxicology 2008; 249: 214-219.
6. CHEN JQ, CAMMARATA PR, BAINES CP, YAGER JD. Regulation of mitochondrial respiratory chain biogenesis by estradiols/estradiol receptors and physiological, pathological and pharmacological implications. Biochim Biophys Acta 2009; 1793: 1540-1570.
7. JANICKI SC, SCHUPF N. Hormonal influences on cognition and risk for Alzheimer's disease. Curr Neurol Neurosci Rep 2010; 10: 359-366.
8. GILLIES GE, MC-ARTHUR S. Estradiol actions in the brain and the basis for differential action in men and women: a case for sex specific medicines. Pharmacol Rev 2010; 62: 155-198.
9. HENDERSON VW, BRINTON RD. Menopause and mitochondria: windows into estradiol effects on Alzheimer's disease risk and therapy. Prog Brain Res 2010; 182: 77-96.
10. NAKAMAGOE M, TABUCHI K, UEMAETOMARI I, NISHIMURA B, HARA A. Estradiol protects the cochlea against gentamicin ototoxicity through inhibition of the JNK pathway. Hearing Res 2010; 261: 67-74.
11. SCHONKNECHT P, PANTEL J, KLINGA K, JENSEN M, HARTMANN T, SALBACH B, SCHRODER J. Reduced cerebrospinal fluid estradiol levels are associated with increased amyloid-beta levels in female patients with Alzheimer's disease. Neurosci Lett 2001; 307: 122-124.
12. A.O.A.C. Official Methods of Analysis. 16th ed. Association of Official Analysis, Washington DC, 1995.
13. WANG Q, SANTIZO R, BAUGHMAN VL, PELLIGRINO DA. Estradiol provides neuroprotection in transient forebrain ischemia through perfusion independent mechanisms in rats. Stroke 1999; 30: 630-637.
14. JULKA D, GILL KD. Effect of aluminum on regional brain antioxidant defense status in Wistar rats. Res Exp Med 1996; 196: 187-194.
15. TSAKIRIS S, SCHULPIS KH, MARINOU K, BEHRAKIS P. Protective effect of L-cysteine and glutathione on the modulated suckling rat brain Na+, K+-ATPase and Mg2+-ATPase activities induced by the in vitro galactosaemia. Pharmacol Res 2004; 49: 475-479.
16. AEBI H. Catalase in vitro. Method Enzymol 1984; 105: 121-126.
17. SATOH K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978; 90: 37-43.
18. KORACEVIC D, KORACEVIC G, DJORDJEVIC V, ANDREJEVIC S, COSIC V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 2001; 54: 356-361.
19. NISHIKIMI M, APPAJI N, YAGI K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun 1972; 46: 849-854.
20. BARBARESCHI M, CAFFO O, VERONESE S, LEEK RD, FINA P, FOX S, BONZANINI M, GIRLANDO S, MORELLI L, ECCHER C, PEZZELLA F, DOGLIONI C, PALMA PD, HARRIS A. Bcl-2 and p53 expression in node negative breast carcinoma a study with long term follow up. Human Pathol 1996; 27: 1149-1155.
21. BARAKAT-WALTER I. Brain derived neurotrophic factor like immunoreactivity is localized mainly in small sensory neurons of rat dorsal root ganglia. J Neurosci Meth 1996; 68: 281-288.
22. DEN BLAAUWEN DH, POPPE WA, TRITSCHLER W. Acetylcholinesterase with acetylthiocholine iodide as substrate: references depending on age and sex with special reference to hormonal effects and pregnancy. J Clin Chem Clin Biochem 1983; 21: 381-386.
23. OSWALD C, SMITS SH, HOING M, SOHN-BOSSER L, DUPONT L, LE RUDULIER D, SCHMITT L, BREMER E. Crystal structures of choline/acetylcholine substrate-binding protein chox from sinorhizobium meliloti in the liganded and unligznded-closed states. J Biol Chem 2008; 283: 32848-32859.
24. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
25. DRURY RAB, WALLINGTON EA. Carleton's Histological Technique, 5th ed. Oxford University Press, Oxford New York Toronto, 1980; pp. 188-189, 237-240, 290-291.
26. ARMITAGE P, BERRY G. Comparison of several groups. In: Statistical Method in Medical Research 2th Ed. Blockwell Significant Publication, Oxford, 1987; pp. 186-213.
27. BHARATHI P, VASUDEVARAJU P, GOVINDARAJU M, PALANISAMY AP, SAMBAMURTI K, RAO KS. Molecular toxicity of aluminum in relation to neurodegeneration. Ind J Med Res 2008; 128: 545-556.
28. TUNEVA J, CHITTUR S, BOLDYREV AA, BIRMAN I, CARPENTER DO. Cerebellar granule cell death induced by aluminum. Neurotoxicol Res 2006; 9: 297-304.
29. KUMAR V, BAL A, GILL KD. Impairment of mitochondrial energy metabolism in different regions of rat brain following chronic exposure to aluminum. Brain Res 2008; 1232: 94-103.
30. HUH JW, CHOI MM, LEE JH, YANG SJ, KIM MJ, CHOI J, LEE KH, LEE JE, CHO SW. Activation of monoamine oxidase isotypes by prolonged intake of aluminum in rat brain. J Inorg Biochem 2005; 99: 2088-2091.
31. TRIPATHI S, MAHDIA AA, NAWABA A, CHANDERA R, HASANB M, SIDDIQUIB MS, MAHDIC F, MITRAD K, BAJPAID VK. Influence of age on aluminum-induced lipid peroxidation and neurolipofuscin in frontal cortex of rat brain: a behavioral, biochemical and ultrastructural study. Brain Res 2009; 1253: 107-116.
32. BEDNAREK-TUPIKOWSKA G, TUPIKOWSKI K, BIDZINSKA B, BOHDANO-WICZ-PAWLAK A, ANTONOWICZ-JUCHNIEWICZ J, KOSOWSKA B, MILEWICZ A. Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy. Gynecol Endocrinol 2004; 19: 57-63.
33. CHEN JQ, CAMMARATA PR, BAINES CP, YAGER JD. Regulation of mitochondrial respiratory chain biogenesis by estradiols/estradiol receptors and physiological, pathological and pharmacological implications. Biochim Biophys Acta 2009; 1793: 1540-1570.
34. HENDERSON VW, BRINTON RD. Menopause and mitochondria: windows into estradiol effects on Alzheimer's disease risk and therapy. Prog Brain Res 2010; 182: 77-96.
35. MUNOZ-CASTANEDA JR, MUNTANE J, MUNOZ MC, BUJALANCE I, MONTILLA P, TUNEZ I. Estradiol and catecholestradiols protect against adriamycin-induced oxidative stress in erythrocytes of ovariectomized rats. Toxicol Lett 2006; 160: 196-203.
36. KUMAR V, BAL A, GILL KD. Susceptibility of mitochondrial super-oxide dismutase to aluminum-induced oxidative damage. Toxicology 2009; 255: 117-123.
37. MENG XM. Mechanism of damage to erythrocytes after burn injury in rat changes in lipid peroxidation, antioxidant function and sulfhydryl groups. Chung Hua Cheng Hsing Shao Shang Wai Ko Tsa Chih 1991; 7: 205-207.
38. NEHRU B, ANAND P. Oxidative damage following chronic aluminum exposure in adult and pup rat brains. J Trace Elem Med Biol 2005; 19: 203-208.
39. GARCIA-SEGURA LM, AZCOITIA I, DON CARLOS LL. Neuroprotection by estradiol. Prog Neurobiol 2001; 63: 29-60.
40. VINA J, SASTRE J, PALLARDO FV, GAMBINI J, BORRAS C. Modulation of longevity-associated genes by estradiols or phytooestradiols. Biol Chem 2008; 389: 273-277.
41. GOTTIPATI S, CAMMARATA PR. Mitochondrial superoxide dismutase activation with 17-beta estradiol-treated human lens epithelial cells. Mol Vis 2008; 14: 898-905.
42. SHARMA K, MEHRA RD. Long term administration of estradiol or tamoxifen to ovariectomized rats affords neuroprotection to hippocampal neurons by modulating the expression of Bcl-2 and Bax. Brain Res 2008; 1204: 1-15.
43. JOHNSON VJ, KIM S, SHARMA RP. Aluminum maltolate induces apoptosis and necrosis in neuro-2a cells: potential role for p53 signaling. Toxicol Sci 2005; 83: 329-339.
44. SAVORY J, HERMAN MM, GHRIBI O. Intracellular mechanisms underlying aluminum-induced apoptosis in rabbit brain. J Inorg Biochem 2003; 97: 151-154.
45. KUMAR V, BAL A, GILL KD. Aluminum-induced oxidative DNA damage recognition and cell cycle disruption in different regions of rat brain. Toxicology 2009b; 264: 137-144.
46. OHYAGI Y, ASAHARA H, CHUI DH, TSURUTA Y, SAKAE N, MIYOSHI K, YAMADA T, KIKUCHI H, TANIWAKI T, MURAI H, IKEZOE K, FURUYA H, KAWARABAYASHI T, SHOJI M, CHECLER F, IWAKI T, MAKIFUCHI T, TAKEDA K, KIRA J, TABIRA T. Intracellular Aβ-42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease. FASEB J 2005; 19: 255-257.
47. TAKUMA K, MATSUO A, HIMENO Y, HOSHINA Y, OHNO Y, FUNATSU Y, ARAI S, KAMEI H, MIZOGUCHI H, NAGAI T, KOIKE K, INOUE M, YAMADA K. 17-β estradiol attenuates hippocampal neuronal loss and cognitive dysfunction induced by chronic restraint stress in ovariectomized rats. Neuroscience 2007; 146: 60-68.
48. CAMPBELL A, BECARIA A, LAHIRI DK, SHARMAN K, BONDY SC. Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. J Neurosci Res 2004; 75: 565-572.
49. NAGATSU T, MOGI M, ICHINOSE H, TOGARI A. Changes in cytokines and neurotrophins in Parkinson's disease. J Neural Transm 2000; 2000: 277-290.
50. VIVIANI B, CORSINI E, GALLI CL, PADOVANI A, CIUSANI E, MARINOVICH M. Dying neural cells activate glia through the release of a protease product. Glia 2000; 32: 84-90.
51. 2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 1998; 20: 709-726.
52. TAPIA-ARANCIBIA L, ALIAGA E, SILHOL M, ARANCIBIA S. New insights into brain BDNF function in normal aging and Alzheimer's disease. Brain Res Rev 2008; 59: 201-220.
53. NILSEN J, BRINTON RD. Mitochondria as therapeutic targets of estradiol action in the central nervous system. Curr Drug Targets CNS Neurol Disord 2004; 3: 297-313.
54. NILSEN J, MOR G, NAFTOLIN F. Estradiol regulated developmental neuronal apoptosis is determined by estradiol receptor subtype and the Fas/Fas ligand system. J Neurobiol 2000; 43: 64-78.
55. SOHRABJI F, LEWI DK. Estradiol BDNF interactions: implications for neurodegenerative diseases. Front Neuroendocrinol 2006; 27: 404-414.
56. SINGH M, MEYER EM, SIMPKINS JW. The effect of ovariectomy and estradiol replacement on brain derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague Dawley rats. Endocrinology 1995; 136: 2320-2324.
57. FINKBEINER S. CREB couples neurotrophin signals to survival messages. Neuron 2000; 25: 11-14.
58. GULYA K, RAKONCZAY Z, KASA P. Cholinotoxic effects of aluminum in rat brain. J Neurochem 1990; 54: 1020-1026.
59. ZHANG J, YANG JQ, HE BC, ZHOU QX, YU HR, TANG Y, LIU BZ. Berberine and total base from rhizoma coptis chinensis attenuate brain injury in an aluminum-induced rat model of neurodegenerative disease. Saud Med J 2009; 30: 760-766.
60. KAIZER RR, CORREA MC, GRIS LRS, DA ROSA CS, BOHRER D, MORSCH VM, ROSA M, SCHETINGER C. Effect of long term exposure to aluminum on the acetylcholinesterase activity in the central nervous system and erythrocytes. Neurochem Res 2008; 33: 2294-2301.
61. ALLEVA K, RANKIN J SANTUCCI D. Neurobehavioural alteration in rodents following developmental exposure to aluminum. Toxicol Ind Health 1998; 14: 209-221.
62. IWASAKI K, HATIP AL-KHATIB I, EGASHIRA N, AKIYOSHI Y, ARAI T, MISHIMA K, TAKAGAKI Y, INUI K, FUJIWARA M. Ovariectomy combined with amyloid-β1-42 impairs memory by decreasing acetylcholine release and α7nAchR expression without induction of apoptosis in the hippocam-pus CA1 neurons of rats. Neurotox Res 2004; 6: 299-309.
63. FARR SA, BANKS WA, MORLEY JE. Estradiol potentiates acetylcholine and glutamate-mediated posttrial memory processing in the hippocampus. Brain Res 2000; 864: 263-269.
64. VALLES SL, DOLZ-GAITON P, GAMBINI J, BORRAS C, LORET AL, PALLARDO FV, VINA J. Estradiol or genistein prevent Alzheimer's disease-associated inflammation correlating with an increase PPARγ expression in cultured astrocytes. Brain Res 2010; 1312: 138-144.
65. LI Y, LIU L, KANG J, SHENG JG, BARGER SW, MRAK RE, GRIFFIN WST. Neuronal-glial interactions-mediated by interleukin-1 enhance neu-ronal acetylcholinesterase activity and mRNA expression. J Neurosci 2000; 20: 149-155.
66. SENER G, ARBAK S, KURTARAN P, GEDIK N, YEGEN BC. Estradiol protects the liver and intestines against sepsis-induced injury in rats. J Surg Res 2005; 128: 70-78.
67. BOHACEK J, BEARL AM, DANIEL JM. Long term ovarian hormone deprivation alters the ability of subsequent oestradiol replacement to regulate choline acetyltransferase protein levels in the hippocampus and prefrontal cortex of middle aged rats. J Neuroendocrinol 2008; 20: 1023-1027.
68. TANABE F, MIYASAKA N, KUBOTA T, ASO T. Estradiol and progesterone improve scopolamine-induced impairment of spatial memory. J Med Dent Sci 2004; 51: 89-98.
69. VAN GROEN T, KADISH I. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology. Brain Res Rev 2005; 48: 370-378.
70. ABD EL-RAHMAN SS. Neuropathology of aluminum toxicity in rats (glutamate and GABA impairment). Pharmacol Res 2003; 47: 189-194.
71. MORINAGA A, HIROHATA M, ONO K, YAMADA M. Estradiol has antiamyloidogenic effects on Alzheimer's amyloid-β fibrils in vitro. Biochem Biophy Res Commun 2007; 359: 697-702.